Ibd Therapy: Novel Targets And Unmet Needs

IBD Therapy: Novel Targets and Unmet Needs

Icahn School of Medicine

Key Insights: Novel Targets for IBD Therapy - Is This the Final Frontier?

Novel Targets and Therapeutic Perspectives in IBD: Beyond Anti-TNF

Tight control and treat to target: How to assess the effectiveness of therapy

Effective Partnering & the Treat-to-Target Approach to IBD Care

Crohn's & Colitis Foundation

Key Insights: Biosimilars and Novel Targets in IBD

Novel Agents for the Treatment of Crohn's Disease

Mechanisms in Medicine

The Evolving Therapeutic Paradigm in IBD: Optimal Positioning of New and Emerging Agents

Improvements in Targeted IBD Management: Innovative Biologics and Small Molecules

Unmet Needs and Updated Goals of Management of IBD

Overview of Novel Therapeutic Approaches to IBD

Key Insights: Mastering Clinical Challenges and Emerging Therapies in IBD

Challenges in IBD Research: Addressing Unmet Needs in IBD Research

Crohn's & Colitis Foundation

Evolving Approaches to IBD Management: From Step-Care to Treat-to-Target

Treat to Target in IBD

Icahn School of Medicine

Current and Evolving Therapeutic Landscape of IBD

Unmet Needs of Therapy for Crohn’s Disease

Positioning of Biologics and New Therapeutics for Crohn's Disease

The urgent unmet need in IBD and the impact on patients

Therapeutic Approaches to IBD in 2020 and Beyond